Article info
PDFExtended report
Genetic markers for the efficacy of tumour necrosis factor blocking therapy in rheumatoid arthritis
- Correspondence to:
Dr L Padyukov, Unit of Rheumatology, Karolinska Institute, CMM L8:O4, 17176, Stockholm, Sweden;
leonid.padyukov{at}cmm.ki.se
Citation
Genetic markers for the efficacy of tumour necrosis factor blocking therapy in rheumatoid arthritis
Publication history
- Accepted November 12, 2002
- First published June 1, 2003.
Online issue publication
October 25, 2017
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Copyright 2003 by Annals of the Rheumatic Diseases